FFRct
Device
HeartFlow, Inc.
Total Payments
$9.1M
Transactions
21,318
Doctors
8,874
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.9M | 9,625 | 5,232 |
| 2023 | $1.6M | 6,066 | 3,249 |
| 2022 | $1.7M | 4,104 | 2,338 |
| 2021 | $2.0M | 1,091 | 637 |
| 2017 | $1.9M | 432 | 246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.4M | 348 | 59.8% |
| Consulting Fee | $1.5M | 604 | 16.1% |
| Food and Beverage | $1.1M | 19,202 | 11.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $734,421 | 339 | 8.1% |
| Travel and Lodging | $218,612 | 783 | 2.4% |
| Education | $148,750 | 24 | 1.6% |
| Space rental or facility fees (teaching hospital only) | $21,000 | 10 | 0.2% |
| Grant | $13,000 | 4 | 0.1% |
| Honoraria | $249.80 | 4 | 0.0% |
Payments by Type
Research
$5.4M
348 transactions
General
$3.6M
20,970 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE | HEARTFLOW, INC. | $2.0M | 0 |
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care | HeartFlow, Inc. | $1.5M | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 438 JACS | HEARTFLOW, INC. | $890,682 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 448 MGH Type 2 MI | HEARTFLOW, INC. | $168,551 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 447 REVEALPLAQUE | HEARTFLOW, INC. | $168,305 | 0 |
| AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management (DECIDE) | HEARTFLOW, INC. | $114,550 | 0 |
| Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) | HEARTFLOW, INC. | $95,895 | 0 |
| Promise - CT - FFR Cost Effectiveness Analysis | HeartFlow, Inc. | $89,560 | 0 |
| SPECT vs CT vs. FFRCT: Diagnostic accuracy (using FFRCT as gold standard) | HeartFlow, Inc. | $78,576 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 437 P3 | HEARTFLOW, INC. | $69,500 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 442 FFRct ACP | HEARTFLOW, INC. | $64,800 | 0 |
| "The AFFECTS Study: Assessment of Fractional Flow reservE Computed Tomography versus Single photon emission computed tomography in the diagnosis of hemodynamically significant coronary artery disease " | HeartFlow, Inc. | $46,464 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 443 ADVANCE-ED | HEARTFLOW, INC. | $42,280 | 0 |
| 100 Analysis : 200 FFRct Analysis : 201 FFRct (Default) | HEARTFLOW, INC. | $30,150 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE | HeartFlow, Inc. | $18,419 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 447 REVEALPLAQUE | HeartFlow, Inc. | $15,730 | 0 |
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CarE | HeartFlow, Inc. | $12,848 | 0 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 443 ADVANCE-ED | HeartFlow, Inc. | $10,360 | 0 |
Top Doctors Receiving Payments for FFRct
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Monroe, NC | $5.7M | 377 |
| , M.D | Cardiovascular Disease | New York, NY | $247,691 | 18 |
| , MD | Cardiovascular Disease | Aurora, CO | $183,531 | 100 |
| , MD | Cardiovascular Disease | Atlanta, GA | $177,453 | 172 |
| , MD | Internal Medicine | Maywood, IL | $165,251 | 103 |
| , MD | Cardiovascular Disease | Troy, MI | $162,788 | 67 |
| , MD | Cardiovascular Disease | Evanston, IL | $79,233 | 49 |
| , M.D | Cardiovascular Disease | Torrance, CA | $55,263 | 66 |
| , M.D | Diagnostic Radiology | Scottsdale, AZ | $50,120 | 47 |
| , M.D | Cardiovascular Disease | Greensboro, NC | $42,859 | 40 |
| , M.D | Internal Medicine | Los Angeles, CA | $42,566 | 40 |
| , MD | Cardiovascular Disease | Nashville, TN | $38,774 | 43 |
| , M.D., M.P.H | Internal Medicine | Glen Ridge, NJ | $38,664 | 34 |
| , MD | Cardiovascular Disease | Greensboro, NC | $36,922 | 43 |
| , MD | Cardiovascular Disease | Royal Oak, MI | $36,610 | 35 |
| , M.D | Family Medicine | Nashville, TN | $35,653 | 42 |
| , M.D | Cardiovascular Disease | Austin, TX | $34,906 | 42 |
| , MD | Internal Medicine | Charlotte, NC | $34,666 | 39 |
| , MD | Student in an Organized Health Care Education/Training Program | Atlanta, GA | $30,935 | 41 |
| , M.D | Internal Medicine | Nashville, TN | $30,000 | 3 |
| , MD | Diagnostic Radiology | Portland, OR | $28,017 | 16 |
| , M.D | Internal Medicine | Skokie, IL | $25,762 | 17 |
| , M.D | Interventional Cardiology | Boston, MA | $25,347 | 10 |
| , MD | Internal Medicine | Pittsburgh, PA | $25,264 | 48 |
| Seth Martin | Cardiovascular Disease | Baltimore, MD | $24,404 | 9 |
Ad
Manufacturing Companies
- HEARTFLOW, INC. $5.3M
- HeartFlow, Inc. $3.7M
Product Information
- Type Device
- Total Payments $9.1M
- Total Doctors 8,874
- Transactions 21,318
About FFRct
FFRct is a device associated with $9.1M in payments to 8,874 healthcare providers, recorded across 21,318 transactions in the CMS Open Payments database. The primary manufacturer is HeartFlow, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.9M was paid across 9,625 transactions to 5,232 doctors.
The most common payment nature for FFRct is "Unspecified" ($5.4M, 59.8% of total).
FFRct is associated with 18 research studies, including "100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE" ($2.0M).